Each share of common stock and each warrant to purchase one share of common stock is being sold at a combined effective price to the public of $0.50.
Gross proceeds from the offering are expected to be ~$2.75M and the offering is expected to close on or about December 26, 2018.
Maxim Group is acting as sole book-running manager for the offering.
Now read: Surface Oncology added to NBI »
Subscribe for full text news in your inbox